VCA
WST icon

Verdence Capital Advisors’s West Pharmaceutical WST Stock Holding History

Verdence Capital Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,091
Closed -$775K – 714
2026
Q1 		$775K Sell
3,091
-251
-8% -$62.5K 0.05% 341
2025
Q4 		$920K Sell
3,342
-5
-0.1% -$1.37K 0.05% 294
2025
Q3 		$961K Buy
3,347
+115
+4% +$27.9K 0.06% 310
2025
Q2 		$707K Buy
3,232
+222
+7% +$47.5K 0.05% 319
2025
Q1 		$674K Buy
3,010
+796
+36% +$219K 0.05% 309
2024
Q4 		$725K Buy
2,214
+5
+0.2% +$1.57K 0.06% 300
2024
Q3 		$663K Buy
2,209
+1,024
+86% +$314K 0.05% 326
2024
Q2 		$390K Buy
1,185
+272
+30% +$96.1K 0.03% 393
2024
Q1 		$361K Buy
+913
New +$338K 0.03% 416

Other funds holding WST

Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
LPPI
Local Pensions Partnership Investment London, United Kingdom $4.77B AUM 20.5% 1-Year Est. Return

Verdence Capital Advisors's WST Position: Q2 2026 in Review

Verdence Capital Advisors sold out of West Pharmaceutical (WST) in Q2 2026, closing a stake of 3,091 shares — an estimated $775K sold.

Verdence Capital Advisors first reported a position in WST in Q1 2024 and held it in 9 quarters. The position peaked at $961K in Q3 2025. 324 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Verdence Capital Advisors reported no remaining West Pharmaceutical position as of Q2 2026 after selling out during the quarter.
  • Verdence Capital Advisors sold 3,091 West Pharmaceutical shares in Q2 2026, an estimated $775K.
  • Verdence Capital Advisors first reported a position in West Pharmaceutical in Q1 2024 and held it in 9 quarters.
  • Verdence Capital Advisors's West Pharmaceutical position peaked at $961K in Q3 2025.
  • 324 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Verdence Capital Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.